Is It Time To Put CSL Limited (ASX:CSL) Shares On Your Watchlist?
Owen Raszkiewicz
December 5, 2018
CSL Limited (ASX:CSL) shares fell 3% Wednesday morning despite a
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
CSL Limited (ASX:CSL) shares fell 3% Wednesday morning despite a
Here are the stories from the S&P/ASX 200 (INDEXASX:XJO)(^AXJO) and
We’ve all heard of the ASX small-cap superstar success stories
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Australia’s share market, or the All Ordinaries Index (INDEXASX:XAO)(ASX:XAO), is
Australia’s share market, or the All Ordinaries Index (INDEXASX: XAO)(ASX:
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
